Get started
UUU

Unitedhealth

No trades
See on Supercharts
Overview News
Ideas
Discussions Seasonals

UNH trade ideas

UNH UnitedHealth Group Incorporated Options Ahead of EarningsIf you haven`t bought UNH before the previous earnings: Then analyzing the options chain and the chart patterns of UNH UnitedHealth Group Incorporated prior to the earnings report this week, I would consider purchasing the 440usd strike price at the money Puts with an expiration date of 2024-4-19, for a premium of approximately $10.65. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NYSE:UNHShort
by TopgOptions
UnitedHealth Group Incorporated (UNH) - Technical Analysis UnitedHealth Group Incorporated (UNH) exhibits technical deterioration as observed in the recent trading sessions. The stock closed at $441.72, experiencing a 1.85% decline. The bearish sentiment is reinforced post-market, with the stock slipping further to $443.00. The technical layout suggests a continuation of the downward trajectory. The price action has decisively breached below the Ichimoku Cloud, a bearish signal indicating that sellers are currently in control. The Cloud’s future span also slopes downward, reinforcing this negative outlook. The Fibonacci retracement levels, drawn from the swing high at $496.20 to the swing low at $431.58, indicate that the price has struggled to reclaim even the 23.6% level at $480.15, showing a lack of bullish momentum. The subsequent support levels at 0.382 ($471.52) and 0.5 ($463.89) have failed to catalyze a rebound, with the current price action hovering just above the 0.618 Fibonacci level at $456.26, which may serve as the next support. The RSI is deep in the oversold territory at 24.36, often considered an area where a potential reversal could occur. However, the continued presence in this region without a significant bounce raises concerns about persistent selling pressure. The MACD remains below the signal line and has widened negatively, indicating strengthening bearish momentum. The absence of a bullish crossover on this oscillator suggests that the path of least resistance remains to the downside. The OBV shows a sharp volume increase on down days, highlighting an aggressive distribution phase. This points to a strong conviction among sellers and is often a precursor to further declines if the pattern persists. Given the bearish technical indicators coupled with the proximity of the next earnings report in four days, traders may expect heightened volatility. The earnings report could act as a pivotal event that either exacerbates the downtrend or triggers a relief rally if the company’s performance exceeds market expectations. Speculatively, should the earnings report provide a positive surprise, resistance levels to watch in a bounce scenario would be the 0.618 Fibonacci level at $456.26 followed by the 0.5 level at $463.89. Conversely, a disappointing report could see the stock testing the 0.786 level at $445.41, with further downside potentially exposing the $431.58 swing low. Investors should brace for increased volatility and trade cautiously, with protective stops and close attention to the forthcoming earnings release, which will likely dictate the short-term trend for UNH’s stock price.
NYSE:UNH
by AxiomEx
Good enter pointNYSE:UNH reached 450 $ recently. From December 2021 never reached bellow this level. It tried 450 $ six times and bounced back to 550 $. From December 2021 NYSE:UNH is is swing in a channel between 450 and 550 $. In weekly chart, it is on 200 days moving average, which seems a very strong support. From December 2021 it always trades above 200 days moving average. In march 2020 it touched the moving average, however, it bounced back and moved higher. I believe NYSE:UNH could easily reach 500 $ in near future and 500 $ is not out of reach. I set my stop loss at 435 $. Good luck to everybody.
NYSE:UNHLong
by Shahi_bak
Medicare Advantage Rates Shake Health Insurers:The healthcare sector witnessed a significant upheaval as UnitedHealth ( NYSE:UNH ) and other major players tumbled following the Biden Administration's announcement regarding Medicare Advantage rates for 2025. The unexpected decision sent shockwaves through the industry, prompting a flurry of market activity and sparking concerns among investors. Impact on Health Insurers: The Biden Administration's announcement that final Medicare Advantage rates in 2025 will remain unchanged from initial plans in January dealt a blow to major health insurers, particularly UnitedHealth and Humana. Both companies, as leading Medicare Advantage players, experienced substantial declines in their stock prices, with Humana plunging 9.4% and UnitedHealth sinking 4% in premarket trading. Market Response and Investor Sentiment: The market response was swift and decisive, with other health insurers such as CVS Health and Cigna also witnessing notable retreats in their stock prices. CVS Health, a significant Medicare Advantage player, saw its stock retreat by 4% overnight, while Cigna experienced a 1.1% dip early Tuesday. Smaller players in the Medicare Advantage market, including Centene and Molina Healthcare, were not spared from the downturn, reflecting the broad impact of the announcement on the industry. Technical Outlook and Bearish Trend: UnitedHealth's stock is currently entrenched in a bearish trend, underscored by a Relative Strength Index (RSI) of 44.88 and trading below its respective Moving Averages (MA). This technical analysis further validates the bearish sentiment surrounding NYSE:UNH stock and highlights the challenges it faces in the current market environment. Implications for the Healthcare Sector: The Biden Administration's decision regarding Medicare Advantage rates in 2025 has far-reaching implications for the healthcare sector, potentially reshaping the competitive landscape and impacting revenue streams for major insurers. As companies navigate this period of uncertainty, strategic agility and resilience will be crucial in mitigating risks and seizing opportunities amidst evolving market dynamics.
NYSE:UNHShort
by DEXWireNews
UNITED HEALTH Time to buy again?Last time we looked into United Health (UNH) we gave a strong buy signal (October 03 2023, see chart below), which turned out to be very successful: After getting rejected on Resistance 3, the stock started to decline structurally within a Channel Down. It is a pattern similar to the Channel Down of November 2022 - March 2023, which was again formed after UNH got rejected within the 2-year Resistance Zone, like it happened this time. There is a high symmetry these past 2 years within the Resistance and Support Zones, so we expect the price to act accordingly. As a result, having already formed a 1D Death Cross, we expect the price to make one last Low towards the Support Zone (as long as the 1D MA50 holds as Resistance) and then rebound, which is what took place on March 10 2023, above the 0.618 Fibonacci retracement level. As a result, we will time our buy accordingly and target $517.00 (Fib 0.618). An additional buy signal would be if the 1W RSI makes a Double Bottom, similar again to March 10 2023. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:UNH
by TradingShot
Healthy Returns: Going Long on United Health GroupThis is a trading idea with a medium-term horizon spanning a few weeks. We're observing United Health Group's stock stabilizing at a significant level on the daily chart. Concurrently, there's an emerging hidden bullish divergence in the OBV, albeit unconfirmed. Given UNH's price reaction at the support zone, we're considering a long trade. Our target is the low of the candle from January 11, 2024, which initiated the as yet unfilled gap. We're doing this because in overarching downtrends, prices tend not to fully close gaps but rather turn at the low of the candle before the gap. While we don't perceive United Health Group to be in a predominant downtrend, given the trade's highly favorable risk-reward ratio of 3:1, we're cautious about unnecessary risks.
NYSE:UNHLong
by Ochlokrat
UNH Stock tumble after report of antitrust investigationUnitedHealth Group ( NYSE:UNH ) finds itself navigating turbulent waters as it confronts both regulatory scrutiny and cybersecurity disruptions. The recent revelation of a U.S. Department of Justice antitrust investigation has sent shockwaves through the healthcare conglomerate, causing its shares to plummet by about 5%. This investigation, as reported by The Wall Street Journal, casts a shadow over UnitedHealth's ( NYSE:UNH ) acquisitions made through its health services arm, Optum, raising concerns about potential monopolistic practices and their impact on competition within the healthcare industry. The timing couldn't be more precarious, as UnitedHealth ( NYSE:UNH ) grapples with the fallout from a cybersecurity attack on its Change Healthcare unit, which has led to an eight-day outage. The prolonged disruption has not only rattled investor confidence but has also triggered operational challenges for the conglomerate and its partners, including pharmacy chains like CVS Health. Analysts are quick to underscore the significance of these developments. Scott Fidel, an analyst at Stephens, aptly describes it as a "tough past week of headlines for UnitedHealth." The market reaction has been swift and severe, with more than $25 billion wiped out from UnitedHealth's market value, exacerbating losses incurred earlier in the week. The ramifications of the reported antitrust probe extend beyond UnitedHealth ( NYSE:UNH ), casting a shadow of uncertainty over its competitors. Humana and CVS Health, both with aspirations in caregiving akin to UnitedHealth's Optum arm, have witnessed declines in their respective stock prices, signaling investor apprehension about the potential ripple effects of the investigation. Julie Utterback, an analyst at Morningstar, underscores the interconnectedness of the healthcare landscape, suggesting that the investigation could have implications for CVS and Humana, especially if it expands further. The specifics of the investigation delve into the intricate relationships between UnitedHealthcare ( NYSE:UNH ) and Optum, probing into potential conflicts of interest and anti-competitive behaviors. Such scrutiny underscores the complexities inherent in the intersection of insurance and healthcare services, where conglomerates like UnitedHealth wield considerable influence. Meanwhile, Change Healthcare continues to grapple with the aftermath of the cybersecurity incident, with disruptions expected to persist. The impact reverberates across the healthcare ecosystem, affecting not only UnitedHealth but also its partners and clients, including pharmacy chains reliant on its services. As UnitedHealth ( NYSE:UNH ) navigates these challenges, stakeholders are left pondering the company's resilience and the broader implications for the healthcare industry. Will regulatory scrutiny force a reassessment of consolidation strategies? Can UnitedHealth ( NYSE:UNH ) effectively mitigate cybersecurity risks and restore trust in its operations?
NYSE:UNH
by DEXWireNews
Buy UNH | Profit Target @ $541UNH has been in a long-term uptrend channel for 6-10 years with steady growth. They're currently bouncing off the bottom of the trend channel within 1 ATR of their AVWAP (anchored from the prior high). The 3 ATR profit target at $541 is $14 above current price representing a 3:1 Risk/Reward. The next major resistance is at $558 ($17 above the target). Adding fuel to the fire, a 65-min TTM squeeze just fired! A March 5/35/540/545 call butterly can be had for .54, which would provide a max profit of $446 and max loss of $54. Alternatively, you could sell the 520 PUT for $5.55 (or maybe do both :)
NYSE:UNHLong
by ThetaGator
2
UNH, the dominate health insurance market leader LONGAs shown on the 4H chart, UNH based on a long-term VWAP band setup, it as fiar value for the first time since September. This dip is significant as price fell from a head and shoulders pattern of three months duration. The candles in the past couple of days show the reversal at the mean VWAP support. I have retrieved 60% out of a near term expiration call option. Some may say this is simply a death cross on a pair of moving averages with a bit of correction on the overall downtrend. I understand that point of view. Notwithstanding that perspective, healthcare is expected to be an outperforming sector in 2024. UNH is on sale. As a healthcare provider, it has paid me large sums in the historical past. I will take trades as described in the text box on the chart. I believe buying out of the money and at a discount will be a good strategy for this megacap moving forward.
ULong
by AwesomeAvani
UNH doji signaling a local low?NYSE:UNH dropped after reducing guidance in their earnings release, and then gapped down again today when NYSE:HUM missed estimates. These two stocks frequently respond to one another, creating fantastic trading opportunities if you have both on your watch list. Todays candle is doji with relatively high volume, which is a decent reversal signal. Prior to today we can see 6 similar dojis during down trends for UNH since January 2022. 5 of them marked the local low. July 2023 was an exception that saw price fall by another 5% over 11 trading days before recovering.
NYSE:UNH
by Ben_1148x2
The Top 3 Confirmation Signals for the Double Top Pattern 1 - Bearish Divergence An indicator such as the RSI showing bearish divergence can confirm the weakening of the bullish trend. 2 - Volume Analysis An increase in selling volume following the second peak reinforces the potential bearish reversal. 3 - Support Breakdown A decisive breakdown below the support level confirms the validity of the double top pattern. Watch this video to learn more -- **Disclaimer:** The information provided above is for educational and informational purposes only. -- It does not constitute financial advice, and trading always involves -- a risk of substantial losses, regardless of the margin levels -- used. Before engaging in any trading activities, it is crucial to -- conduct thorough research, consider your financial situation, -- and, if necessary, consult with a qualified financial advisor. Past -- performance is not indicative of future results, and market -- conditions can change rapidly. Trading decisions should be made -- based on careful analysis and consideration of individual -- circumstances. The user is solely responsible for any decisions made -- and should be aware of the inherent risks associated with trading in -- financial markets.
NYSE:UNHEducation
by lubosi
1